Skip to content

A study comparing the efficacy of radio frequency energy versus light energy based laser in the treatment of cherry angioma

A comparative study on the efficacy of radiofrequency ablation versus intense pulsed light in the treatment of cherry angioma - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/12/060679
Enrollment
50
Registered
2023-12-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I789- Disease of capillaries, unspecified

Interventions

Intervention1: Radio frequency ablation: Patients in group A will be treated with radio frequency ablation in coagulation mode and followed up at one week,one month and three months interval and final

Sponsors

Dr.S.Shanthini
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either sex above 18 years & below 60 years with cherry angioma. Patients willing to give a written informed consent.

Exclusion criteria

Exclusion criteria: Before starting the study Pregnant and lactating women. Women planning for pregnancy Patients with co-morbidities – DM /TB /CAD Patients with IED Patients on immunosuppressive drugs,anti coagulants , isotretinoin Bleeding and coagulation disorders, HIV , Hep B , Hep C Patients with active local infection and photoaggravated skin diseases Patients with unstable vitiligo , psoriasis and keloids During Study If patient develops severe side effects like ulceration / intolerant to pain during the treatment If patient wants alternate treatment during the study. If patient wants to discontinue the treatment.

Design outcomes

Primary

MeasureTime frame
Resolution of lesions clinicallyTimepoint: One week ,one month,three months,six months for radio frequency ablation Each treatment sessions (4,8,12,16 weeks ) and 6 months for intense pulsed light

Secondary

MeasureTime frame
Scarring,hyperpigmentation , recurrence of lesionsTimepoint: 24 weeks

Countries

India

Contacts

Public ContactDrVSridhar

Chengalpattu medical college hospital

dermcliniccmch@gmail.com9865653399

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026